The data reported here are in general agreement with a previous study conducted by Yi et al., in which Pak inhibition by shRNAs reduced tumor volume of dominant-negative NF2-expressing cells [32], but also have some intriguing differences. This evidence concerns the gene NF2 and neoplasm.